跳至主要内容
临床试验/CTRI/2024/09/074250
CTRI/2024/09/074250进行中(未招募)2/3 期

Comparing the Therapy of Otomycosis Using Clotrimazole Cream versus Clotrimazole Ear Drops: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Hind Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年9月25日最近更新:

试验速览

阶段
2/3 期
状态
进行中(未招募)
发起方
入组人数
150
试验地点
1
主要终点
Clinical cure will be assessed through otoscopic examination and symptom evaluation, including the resolution of ear itching, discharge, and redness. Measurements will be taken at baseline and after 4 weeks of treatment.

研究概览

简要总结

Recruitment Status SummaryStudy Title- Clotrimazole Cream versus Ear Drops for Otomycosis - A RANDOMIZED TRIAL

**Background-**Otomycosis, a fungal infection of the ear canal, is commonly treated with antifungal agents. Clotrimazole is a well-established treatment for this condition, available in various forms, including creams and ear drops. Despite its effectiveness, the optimal formulation for treating otomycosis has not been definitively established. Creams are typically used for skin infections, while ear drops are designed for ear canal application.

Purpose of Trial- This randomized controlled clinical trial was done to compare the efficacy and safety of clotrimazole cream versus clotrimazole ear drops in treating otomycosis. By evaluating both treatments head-to-head, the trial determined that clotrimazole cream is more effective than ear drops in treating uncomplicated otomycosis. Its occlusive application and higher compliance may contribute to superior clinical outcomes.

**Date-**02/06/2025] Principal Investigator- DR. SYED MOHD AHMAD Institution- HIND INSTITUTE OF MEDICAL SCIENCES

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis: Confirmed otomycosis with positive fungal culture or microscopy.
  • Age: Adults aged 18 years to 50 years.
  • Symptom Duration: Symptoms present for at least [duration, e.g., 2 weeks].
  • Ear Condition: Active otomycosis with itching, discharge, and/or pain.
  • Compliance: Ability to adhere to the treatment protocol.
  • Informed Consent: Written informed consent obtained.
  • Contraindications: No known hypersensitivity to clotrimazole.
  • General Health: Overall good health with no severe concurrent ear conditions.
  • Antifungal Treatments: No recent use of other antifungal treatments within [duration, e.g., 4 weeks].

排除标准

  • Non-Fungal Ear Infections: Diagnosis of other ear infections or significant ear pathologies.
  • Hypersensitivity: Known allergy to clotrimazole or its components.
  • Concurrent Antifungal Therapy: Recent use of other antifungal treatments.
  • Immunocompromised Conditions: Conditions affecting immune function.
  • Recent Ear Surgery: Recent ear surgery or trauma.
  • Pregnancy and Breastfeeding: Pregnant or breastfeeding women.
  • Severe Medical Conditions: Severe or uncontrolled medical conditions.
  • Inability to Follow Protocol: Inability to comply with treatment and follow-up.
  • Concurrent Participation in Another Study: Participation in other studies that may interfere.
  • Other Contraindications: Any other factors posing risk or affecting study results.

结局指标

主要结局

Clinical cure will be assessed through otoscopic examination and symptom evaluation, including the resolution of ear itching, discharge, and redness. Measurements will be taken at baseline and after 4 weeks of treatment.

时间窗: 1 week

次要结局

  • Reduction in fungal load.(Improvement in patient-reported symptoms.)

研究者

发起方
Hind Institute of Medical Sciences
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Syed Mohd Ahmad

Hind Institute of medical sciences

研究点 (1)

Loading locations...

相似试验